[December 18, 2014]

Research and Markets: MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts 2013-2020

Research and Markets (http://www.researchandmarkets.com/research/2ksxvc/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts" report to their offering.

The authors estimate the global nuclear imaging market to have been worth $1.77 billion in 2012 and $1.83 billion in 2013. The authors estimate that this market will be worth $2.2 billion in 2020, increasing at a Compound Annual Growth Rate (CAGR) of 3.3% during the period of 2014 to 2020.

The nuclear imaging market is a moderately growing market with a 2014-2020 CAGR of 3.3% globally. It is a mature sector of the diagnostic imaging market; continued growth is expected along with continued technological developments and the emerging markets' acceptance of products.

US Dominates the Nuclear Imaging Market

In 2012, the US dominated the global nuclear imaging market, accounting for 69% of sales globally. The market is dominated by three companies: the market leader is Philips (News - Alert) Healthcare with around 35% of the market by revenue, followed closely by GE Healthcare with around 33% of the market, an Siemens Healthcare at just under 30%.

Demand for Nuclear Imaging in US to Become Static

The US is the largest market for nuclear imaging, in terms of the number of systems sold and the number of procedures carried out. However, a period of a rapid increase in procedures in the US, particularly PET and PET/CT, has led to measures to reduce the number of procedures that can be reimbursed, and thus reduce the demand for nuclear imaging systems. Prior to healthcare reform, the major threat to the US nuclear imaging market was the limited supply of radiopharmaceuticals.

The key drivers for the global nuclear imaging market are:

• Aging population and increasing disease prevalence
• Increasing referring physician awareness
• Increasing defensive medicine
• Increasing patient awareness
• Increasing self-referral behavior
• Increasing implementation of comparative effectiveness research
• Improved accreditation of imaging facilities
• Availability of new imaging reagents
• Increasing demand for cancer diagnoses
• Increasing demand for imaging-based companion diagnostics
• Replacement of positron emission tomography (PET)/computed tomography (CT) by PET/magnetic resonance imaging (MRI)
• Replacement of single-photon emission computed tomography (SPECT)-only systems

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Industry Overview

4 Unmet Needs

5 Market Opportunity Analysis

6 Market Drivers and Barriers

7 Competitive Assessment

8 Pipeline Assessment

9 Clinical Trials to Watch

10 Current and Future Players

11 Market Outlooks

12 Appendix

Companies Mentioned

• DDD-Diagnostic
• Digirad
• GE Healthcare
• GVI Medical Devices
• Mediso Medical Imaging Systems (News - Alert)
• NeuroLogica
• Neusoft Medical Systems
• NuCare Medical Systems
• Oncovision
• Philips Healthcare
• Shimadzu
• Siemens (News - Alert) Healthcare
• SurgicEye
• Toshiba Medical

For more information visit http://www.researchandmarkets.com/research/2ksxvc/medipoint.

[ Back To TMCnet.com's Homepage ]